CD36 and metabolic dysfunction-associated steatotic liver disease: Our findings demonstrate that both HFD and palmitic acid alter global and pparγ-promoter DNA methylation, leading to strong induction of the expression of PPARγ, CD36, and VLDLR and enhanced fat accumulation in the liver, an initiation step in the development of NAFLD.